In AML, IGF2BP2 stabilizes protein arginine methyltransferase 6 (PRMT6) and subsequently downregulates the expression of the lipid transporter major facilitator superfamily domain containing 2A (MFSD2A), thereby maintaining the function of leukemia stem cells.414. The gene discussed is IGF2BP2; the disease is acute myeloid leukemia.